Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Banco Fonder
Stockholm, Sweden
- Ownership
- Private
- Development stage
- Other
01
Overview
Banco Fonder was a Swedish asset management company that specialized in ethical and socially responsible investment (SRI) strategies. While primarily a financial institution, it was significant to the biotech sector as the manager of the Banco Biotech fund, which invested in global life science and pharmaceutical equities. The firm was a pioneer in thematic investing in the Nordic region, using ESG criteria to screen its holdings. In 2009, Banco Fonder was acquired by Swedbank Robur, leading to the consolidation of its funds into Swedbank's portfolio. The company no longer operates as an independent entity, and its specialized biotech investment products have since been integrated or rebranded.
- Industry
- Investors
Beyond the preview
Go deeper on Banco Fonder.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Banco Fonder.